Breaking Down Hengan International Group Company Limited Financial Health: Key Insights for Investors

Curious whether Hengan International (1044.HK) is weathering the storm or signaling deeper trouble? In the first half of 2025 the group reported a near-flat revenue change of RMB 11.81 billion (down 0.2% YoY) on the back of a RMB 22.67 billion full-year top line for 2024 (a decline of 4.62%), while e-commerce and new retail surged 7.9% to account for 34.4% of sales-growth that offsets some softness as tissue paper gains partly counter declining hygiene products; yet margins slipped (gross margin down to 32.30% in 2024 from 33.71% and net profit margin to 10.14%) amid higher fluff pulp and promotional spend even as operating cash flow remained resilient (OCF/net income ratio 1.34), leverage improved (debt-to-equity 0.63; net debt/equity 0.7%) and valuation multiples show a trailing P/E of 12.87 with market cap at HKD 32.53 billion-contrasting signals further complicated by liquidity and distress metrics (current ratio 1.16, quick ratio 0.99, Altman Z‑Score 2.16, Piotroski F‑Score 5) and a modest ROE of 10.99%-dig into the detailed revenue, profitability, leverage and valuation sections below to weigh risk versus opportunity.

Hengan International Group Company Limited (1044.HK) - Revenue Analysis

• H1 2025 revenue: RMB 11.81 billion (down 0.2% YoY)
• Full-year 2024 revenue: RMB 22.67 billion (down 4.62% YoY)
• Primary headwinds: intensified competition and elevated raw material costs
• Operational stability: finished goods turnover and trade receivables turnover remained stable
• Channel mix shift: e-commerce and new retail +7.9% YoY, now 34.4% of total revenue
• Segment dynamics: tissue paper growth partially offset hygiene products decline

• Revenue mix implication: rising online/new retail penetration cushions retail-channel weakness and supports margins if logistics and acquisition costs are controlled
• Inventory & working capital: stable turnovers suggest no acute working‑capital strain despite revenue decline

Hengan International Group Company Limited (1044.HK) Profitability Metrics

• Gross profit margin: 33.71% (2023) → 32.30% (2024)
• Net profit margin: 11.78% (2023) → 10.14% (2024)
• Operating profit (H1 2025): RMB 1.76 billion, down 7.3% YoY
• Profit attributable to shareholders (H1 2025): RMB 1.37 billion, down 2.6% YoY
• Operating cash flow to net income ratio: 1.34 (stable)
• Main drivers: increased promotional expenses and higher fluff pulp costs

• Implication for margins: Lower gross margin reflects input-cost pressure; lower net margin reflects both cost and elevated marketing/promotional spend.
• Cash quality: Operating cash flow to net income ratio of 1.34 indicates cash generation remains stronger than reported earnings, providing a buffer for working capital and investment.
• Short-term outlook factors to monitor: fluff pulp price trajectory, promotional intensity, and any efficiency gains in manufacturing/SG&A.

Hengan International Group Company Limited (1044.HK) - Debt vs. Equity Structure

• Debt-to-equity ratio: improved to 0.63 in 2024 from 0.70 in 2023, indicating reduced leverage and a lighter reliance on borrowed funds.
• Equity ratio: rose to 52.55% in 2024 from 50.70% in 2023, reflecting a stronger portion of assets financed by shareholders' equity.
• Net debt to equity: 0.7% in 2024, effectively very low net leverage once cash and equivalents are netted against borrowings.
• Current ratio: 1.16 in 2024, suggesting adequate short-term liquidity to meet near-term obligations.
• Interest coverage ratio: 7.15 in 2024, indicating operating earnings cover interest expense by a comfortable margin.
• Return on equity (ROE): 10.99% in 2024, down from 13.73% in 2023, primarily due to lower net income despite stronger equity base.

Hengan International Group Company Limited (1044.HK) - Liquidity and Solvency

• Current ratio: 1.16 - adequate headroom to meet short-term liabilities (current assets exceed current liabilities by 16%).
• Quick ratio: 0.99 - near 1:1 suggests limited cushion if inventory cannot be quickly converted to cash.
• Net debt to equity: 0.7% - very low net leverage, indicating equity largely finances the business and minimal net borrowing.
• Interest coverage ratio: 7.15 - earnings before interest and taxes cover interest expense more than seven times, implying comfortable servicing of debt.
• Altman Z-Score: 2.16 - falls into the 'distress zone' threshold area (increased bankruptcy risk relative to healthy firms).
• Piotroski F-Score: 5 - an average score reflecting mixed signals across profitability, leverage/liquidity, and operating efficiency.

• Investor implications: the low net debt and strong interest coverage reduce solvency concerns today, but the near-1 quick ratio and Altman Z-Score near the distress threshold suggest monitoring working capital trends, inventory turnover, and any potential earnings deterioration.
• Actionable monitoring items: track quarterly changes in cash, receivables, inventories, EBIT, and any shifts in short-term borrowing or covenant terms.

Hengan International Group Company Limited (1044.HK) - Valuation Analysis

• Trailing P/E: 12.87
• Forward P/E: 12.21
• P/S: 1.31
• P/B: 1.37
• EV/EBITDA: 8.10
• EV/FCF: 15.83
• PEG: 4.83
• Market Capitalization: HKD 32.53 billion
• Enterprise Value: HKD 32.99 billion
• Beta: 0.58

• Interpretation of multiples: P/E and EV/EBITDA indicate a valuation in line with mature consumer staples peers, but the high PEG (4.83) suggests earnings growth expectations are low relative to current price.
• Balance of market cap and EV: With EV (HKD 32.99B) close to market cap (HKD 32.53B), net debt is minimal, implying leverage is limited and valuation is driven primarily by equity value.
• Volatility and risk: Beta of 0.58 implies lower sensitivity to market swings, supporting defensive characteristics for income-oriented or risk-averse investors.
• Cash flow perspective: EV/FCF of 15.83 signals a pricier cash-flow multiple compared with the EV/EBITDA of 8.10, highlighting potential differences between accounting earnings and free cash generation.

Hengan International Group Company Limited (1044.HK) - Risk Factors

• Intensified competition in personal hygiene products: domestic and international players have pushed pricing and promotional pressure, slowing volume growth and compressing margins.
• Rising raw material costs - especially fluff pulp - which have increased input costs materially and pressured gross margins.
• Financial distress indicators: an Altman Z-Score of 2.16 points to heightened bankruptcy risk relative to stronger, safer firms.
• Mixed operational quality: a Piotroski F-Score of 5 signals average financial health and limited evidence of consistent improvement in fundamentals.
• Working capital/liquidity constraints: a quick ratio of 0.99 suggests limited ability to cover short-term liabilities without relying on inventory liquidation.
• Declining profitability metrics (net profit margin and ROE) that may harm investor confidence and valuation multiples.

• Operational implications: margin compression from raw material inflation and promotional spending reduces free cash flow and limits reinvestment capacity.
• Liquidity and solvency concerns: Altman Z-Score near distress range plus quick ratio <1.0 increases the importance of cash management, working capital optimization, and access to credit.
• Investor sentiment risk: falling net profit margin and ROE (3.8% and 7.2% respectively in FY2023) can depress valuations and make equity financing more costly.
• Competitive threat: intensified price competition raises the risk of market-share loss unless Hengan differentiates on brand, cost, or distribution.

Hengan International Group Company Limited (1044.HK) - Growth Opportunities

• E-commerce and New Retail: e-commerce and new retail channels now account for 34.4% of total revenue, up from ~27% two years prior, driven by deeper penetration on platforms and DTC initiatives.
• Tissue Paper Momentum: Tissue paper segment shows mid-single-digit to high-single-digit volume growth in recent quarters, partially offsetting softness in premium hygiene products.
• Product Line Diversification: Recent launches in home-cleaning wipes and eco-friendly tissue variants broaden addressable market and margin mix.
• Geographic Expansion: Underserved inland and lower-tier city markets in mainland China and selective Southeast Asian markets present sizable volume upside.
• R&D Investment: Increased R&D allocation-targeting product formulation, sustainable materials, and packaging-supports premiumization and cost optimization.
• Strategic M&A & Partnerships: Opportunities for bolt-on acquisitions and distribution partnerships to accelerate scale and channel coverage.

• Priority actions to capture growth:
• Scale e-commerce: deepen marketplace presence, optimize digital marketing ROI, and expand direct-to-consumer fulfillment.
• Product innovation: accelerate sustainable and premium product launches to lift ASPs and margins.
• Channel mix management: shift sales effort toward faster-growing online and new retail partners while maintaining traditional retail distribution.
• Targeted M&A: pursue acquisitions that add distribution, private-label capabilities, or technology for supply-chain efficiency.
• Geographic rollout: pilot entry into select Southeast Asian markets and deeper penetration into China's lower-tier cities.